Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2019

Nov 26, 2019

30339_dirs_2019-11-26_2837c17e-241c-4c86-b182-659ead188c3b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2019-11-22

Reporting Person: MILLER GEORGE LLOYD (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-11-22 Common Stock F 2151.00 $149.72 Disposed 6528.6517 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 17926.4554 Indirect

Footnotes

F1: Shares withheld solely for the purpose of satisfying tax liability due upon vesting of restricted stock award.